BST: Anthropic IPO And Large Dividend Boost Ahead

BlackRock Science and Technology Trust is trading at an 11.46% discount to NAV, its deepest in years, while offering a 6.2% dividend yield with strong coverage. The fund is positioned to benefit from AI momentum and provides early exposure to Anthropic ahead of a potential IPO. The setup is constructive for income investors, with a high likelihood of a supplemental payout or base raise by year-end.

Analysis

The deeper signal here is not just a cheap closed-end fund; it is that public-market investors are effectively being paid to warehouse late-stage AI optionality at a discount while the private-market re-rating remains incomplete. If secondary pricing for private AI names keeps marking up, the NAV discount should be the first release valve, because the market typically closes discounts before it fully capitalizes the embedded venture exposure. That creates a double lever: NAV appreciation from AI beta plus mean reversion in the discount, which is a more attractive setup than owning pure public AI leaders at full price.

The likely second-order winner is the private-capital ecosystem around AI infrastructure and model development: as a listed vehicle with recognizable exposure performs, it can improve mark-to-market confidence for other crossover and late-stage funds. That may support a broader compression in risk premia for private tech assets over the next 1-2 quarters, especially if IPO windows reopen and comparables such as model-layer and application-layer names begin trading well. Conversely, public names that rely on scarcity value rather than fundamentals are vulnerable if BST becomes the cheaper way to express the same theme.

The main risk is timing: the discount can stay wide for months if rates back up, tech breadth narrows, or the market questions the pace of monetization in frontier AI. The dividend catalyst matters because income-oriented capital can be a powerful stabilizer, but if the distribution is perceived as unsustainable, the stock could de-rate quickly despite a strong narrative. In other words, the setup is attractive, but the trade works best if AI sentiment stays constructive through the next 1-2 earnings seasons and the IPO pipeline actually opens rather than merely being discussed.

Consensus may be underestimating the convexity of sentiment around an eventual Anthropic listing: the first public read-through on a marquee private AI asset tends to reprice the entire adjacent ecosystem, not just the direct holder. That means BST is less a pure income trade than a call option on a reopening of the AI private-markets bid, with the discount to NAV providing a built-in margin of safety. The market may be pricing BST as a sleepy trust when it is really a liquidity-bridged proxy for the next leg of AI asset inflation.

Key Decisions for Investors

• Long BST as a 3-6 month mean-reversion + AI-beta trade; size for a 10-15% discount narrowing versus 5-8% downside if tech sentiment weakens.
• Buy BST against a short in a high-multiple public AI beneficiary with limited balance-sheet support; the goal is to isolate private-market optionality versus crowded public AI exposure.
• Consider a call-spread on BST into the next 1-2 quarters to capture discount compression and any IPO-related re-rating while limiting drawdown if the discount persists.
• If BST trades above a materially tighter discount on volume expansion, trim 25-50% of the position; the easy money is the first half of the discount closure, not the final few points.